Population Diagnostics




Population Diagnostics discovers causative genetic biomarkers to:

  • Develop and market DNA-based diagnostic tests for pre-symptomatic early detection of disease.
  • Enable pharmaceutical companies to develop companion diagnostics and novel targeted drugs with greater efficacy and safety.

Outlicensing Opportunities

Population Diagnostics has intellectual property portfolios in Parkinson’s disease and Autism Spectrum Disorder comprising causative biomarker collections for both therapeutic and diagnostics applications. In addition to active discovery programs in a variety of diseases (see figure), our technology highly enables the cytogenetics diagnostic market. Population Diagnostics pursues alliances with microarray providers serving the cytogenetics community.



Leave a comment

February 18, 2013 · 10:23 pm

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s